autologous dopaminergic cell implantation for parkinson disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Nov 2024: Trial registered, NCT06687837
  2. 29 Apr 2025: Trial started, NCT06687837

The trials

NCT06687837: Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons

State
Under way
Phase
Phase 1
People
8 planned
Started
29 Apr 2025
Primary completion
Dec 2027
Arms
Low dose administration, High dose administration
Results
None posted
  1. 14 Nov 2024: Trial registered
  2. 29 Apr 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.